Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Genetics
Diagnostic tool enables analysis of molecular characteristics of breast tumors
April 6th, 2004
Significant progress towards identifying the genetic make-up of individual tumors, hence allowing treatment choices to be made based on personalized information, was announced at the 4th European Breast Cancer Conference on March 17, 2004. Alane Koki, chief scientific officer of Ipsogen, a French biotechnology company, told a news briefing that, subject to the successful conclusion of ongoing validation studies, the Breast Cancer ProfileChip (BCPC) should be available for use in pathology laboratories by summer 2004. One of the biggest obstacles to effective breast cancer treatment and management is the amount of genetic variability between patients....
Source: Cancer Weekly (2004-04-06)
|
